Wang, L., & Mackensen, F. (2018). S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology, 57(7), . https://doi.org/10.1093/rheumatology/key090
Chicago Style (17th ed.) CitationWang, Lin, and Friederike Mackensen. "S100A12 and S100A8/9 Proteins Are Biomarkers of Articular Disease Activity in Blau Syndrome." Rheumatology 57, no. 7 (2018). https://doi.org/10.1093/rheumatology/key090.
MLA (9th ed.) CitationWang, Lin, and Friederike Mackensen. "S100A12 and S100A8/9 Proteins Are Biomarkers of Articular Disease Activity in Blau Syndrome." Rheumatology, vol. 57, no. 7, 2018, https://doi.org/10.1093/rheumatology/key090.
Warning: These citations may not always be 100% accurate.